BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: HER2
1
Long-term follow-up of HER2 overexpression in patients with rectal cancer after preoperative radiotherapy: A prospective cohort study
10/14/2022 12:54:50 PM | Browse: 232 | Download: 590
2
New horizons for uncommon mutations in non-small cell lung cancer: BRAF, KRAS, RET, MET, NTRK, HER2
4/22/2022 8:49:02 AM | Browse: 261 | Download: 498
3
Molecular testing for colorectal cancer: Clinical applications
10/13/2021 12:57:54 PM | Browse: 381 | Download: 713
4
Complete response to trastuzumab and chemotherapy in recurrent urothelial bladder carcinoma with HER2 gene amplification: A case report
2/6/2020 2:37:44 AM | Browse: 663 | Download: 738
5
Recent progress of chemotherapy and biomarkers for gastroesophageal cancer
7/15/2019 10:30:02 AM | Browse: 738 | Download: 1235
6
HER2-induced metastasis is mediated by AKT/JNK/EMT signaling pathway in gastric cancer
11/6/2016 3:43:00 PM | Browse: 949 | Download: 1539
7
HER2 aberrations and heterogeneity in cancers of the digestive system: Implications for pathologists and gastroenterologists
9/14/2016 7:04:00 PM | Browse: 1125 | Download: 1580
8
HER2 heterogeneity in gastric/gastroesophageal cancers: From benchside to practice
7/6/2016 4:53:00 PM | Browse: 1046 | Download: 1618
9
Differences in HER2 over-expression between proximal and distal gastric cancers in the Chinese population
9/16/2014 9:54:00 AM | Browse: 984 | Download: 631
10
Targeting autophagy in breast cancer
8/22/2014 5:28:00 PM | Browse: 1198 | Download: 1191
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345